MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Bone Marrow Neoplasms

(UMLS:C0282609)

Definition:: Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as MULTIPLE MYELOMA. Most bone marrow neoplasms are metastatic.
UMLS ID:: C0282609
MeSH ID:: D019046

Classification 1:

Name:

Neoplasms
MeSH Tree Number(s):: C04.588.448.200

Classification 2:

Name:

Hemic and Lymphatic Diseases
MeSH Tree Number(s):: C15.378.190.250|C15.378.400.200

Synonym(s)

Bone Marrow Neoplasms

Bone Marrow Neoplasm

Bone Marrow Tumor

Neoplasm of Bone Marrow

Neoplasm of bone marrow

bone cancer marrow

bone marrow cancer

bone marrow neoplasm

bone marrow neoplasms

10.

cancer bone marrow

11.

neoplasm of bone marrow

Associated Drug(s)

	Name	Reference(s)	Data Source
1	Azathioprine	20026017	CTD
2	BEACOPP protocol	20026017	CTD
3	Cyclophosphamide	2214347	CTD
4	Dactinomycin	14601052	CTD
5	Doxorubicin	14601052	CTD
6	Etoposide	14601052	CTD
7	Methotrexate	2214347	CTD
8	Mitoxantrone	2214347	CTD
9	Prednisolone	2214347	CTD
10	Pregabalin	22539615	CTD
11	Vincristine	2214347	CTD
12	fludarabine	20026017	CTD
13	nitrobenzene	8050629	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Thrombocythemia, Essential	42.8%
2	Disseminated Intravascular Coagulation	40%
3	Protein S Deficiency	40%
4	Thrombocytosis	35.8%
5	MYELODYSPLASTIC SYNDROME	33.3%
6	Hemoglobinuria, Paroxysmal	31.6%
7	Leukemoid Reaction	31.6%
8	Thrombasthenia	31.3%
9	Antithrombin III Deficiency	31.3%
10	Protein C Deficiency	31.3%
11	Anemia	30.5%
12	Blood Coagulation Disorders	30.5%
13	Blood Platelet Disorders	30.5%
14	Hemorrhagic Disorders	30.5%
15	Leukocyte Disorders	30.5%
16	Methemoglobinemia	30.5%
17	Pancytopenia	30.5%
18	Polycythemia	30.5%
19	Sulfhemoglobinemia	30.5%
20	Thrombophilia	30.5%
21	Erythrocytosis	30.5%
22	Afibrinogenemia	28.3%
23	Factor VII Deficiency	28.3%
24	Factor X Deficiency	28.3%
25	Factor XII Deficiency	28.3%
26	Hemophilia A	28.3%
27	Activated Protein C Resistance	28.3%
28	Factor II deficiency	28.3%
29	Factor VIII Deficiency	28.3%
30	Factor V deficiency	28.3%
31	Factor XI Deficiency	28.3%
32	Hypoprothrombinemias	28.3%
33	Anemia, Diamond-Blackfan	27.1%
34	Vitamin K Deficiency	26.4%
35	Transfusion Reaction	25.4%
36	Hypotensive Transfusion Reaction	25.4%
37	Primary Myelofibrosis	24.8%
38	Myelofibrosis	24.8%
39	Myeloid Metaplasia	24.8%
40	bone marrow fibrosis	24.8%
41	Pregnancy Complications, Hematologic	24.7%
42	Polycythemia Vera	22.4%
43	Leukemia, Myelomonocytic, Chronic	21.7%
44	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	21.7%
45	Purpura, Thrombotic Thrombocytopenic	21.3%
46	Wiskott-Aldrich Syndrome	20.9%
47	Anemia, Hemolytic	20%
48	Anemia, Macrocytic	20%
49	Eosinophilia	20%
50	Hypoproteinemia	20%
51	Leukopenia	20%
52	Thrombocytopenia	20%
53	Leukostasis	20%
54	Fanconi Anemia	18.8%
55	Anemia, Sickle Cell	18.4%
56	Thalassemia	18.4%
57	Agammaglobulinemia	18%
58	Leukemia, Myeloid, Chronic-Phase	18%
59	Waldenstrom Macroglobulinemia	17.6%
60	Splenic Neoplasms	17.6%
61	Lymphatic Diseases	17.5%
62	Autoimmune thrombocytopenia	17.4%
63	Immune thrombocytopenic purpura	17.4%
64	Cryoglobulinemia	17%
65	Monoclonal Gammopathy of Undetermined Significance	17%
66	Anemia, Neonatal	16.2%
67	Leukocytosis	16.2%
68	Paraproteinemias	16.2%
69	Pelger-Huet Anomaly	16.2%
70	Pleocytosis	16.2%
71	Thymus Neoplasms	16.2%
72	Hemolytic-Uremic Syndrome	15.3%
73	Abdominal Neoplasms	15.3%
74	Bone Marrow Diseases	15.3%
75	Head and Neck Neoplasms	15.3%
76	Soft Tissue Neoplasms	15.3%
77	Thoracic Neoplasms	15.3%
78	Infectious Mononucleosis	15.2%
79	Agranulocytosis	14.9%
80	Anemia, Megaloblastic	14.9%
81	Lymphocytosis	14.9%
82	Hypoalbuminemia	14.9%
83	Hypereosinophilic syndrome	14.9%
84	Thrombotic Microangiopathies	14.9%
85	Purpura, Hyperglobulinemic	14.8%
86	Multiple Myeloma	14.7%
87	Sickle Cell Trait	14.7%
88	Heavy Chain Disease	14.4%
89	Thrombocytopenic purpura	13.8%
90	Hypergammaglobulinemia	13.6%
91	Transfusion-Related Acute Lung Injury	13.4%
92	Ecchymosis	13.3%
93	Petechiae	13.3%
94	Purpura	13.3%
95	Bone Marrow Neoplasms	13.3%
96	Atypical Hemolytic Uremic Syndrome	13.2%
97	Hydrops Fetalis	12.9%
98	Digestive System Neoplasms	12.7%
99	Endocrine Gland Neoplasms	12.7%
100	Eye Neoplasms	12.7%
101	Nervous System Neoplasms	12.7%
102	Neutropenia	12.3%
103	Bone neoplasms	12.3%
104	Lymphocele	12.3%
105	Skin Neoplasms	12.3%
106	Hematologic Neoplasms	12.3%
107	Lymphopenia	12.1%
108	Job Syndrome	11.9%
109	Parathyroid Neoplasms	11.7%
110	Peritoneal Neoplasms	11.7%
111	Thyroid Neoplasm	11.7%
112	Thyroid carcinoma	11.7%
113	Acute Chest Syndrome	11.6%
114	Thymoma	11.6%
115	Hemangioma, Cavernous	11.5%
116	Waterhouse-Friderichsen Syndrome	11.4%
117	Febrile Neutropenia	11.1%
118	Multiple Endocrine Neoplasia	10.3%
119	Pancreatic Neoplasm	10.3%
120	Paraneoplastic Encephalomyelitis	10.2%
121	Adenitis	10.2%
122	Histiocytosis	10.2%
123	Lymphadenitis	10.2%
124	Lymphangitis	10.2%
125	Lymphedema	10.2%
126	Splenic Diseases	10.2%
127	Thymus Hyperplasia	10.2%
128	Pseudolymphoma	10.2%
129	Lymphadenopathy	10.2%
130	Tracheal Neoplasms	10.1%
131	Mammary Neoplasms, Experimental	10.1%
132	Eosinophilia-Myalgia Syndrome	10.1%
133	Pulmonary Eosinophilia	10%
134	Eosinophilic Pneumonia	10%
135	Retroperitoneal Neoplasms	10%
136	Eosinophilic Granuloma	10%
137	Chronic granulomatous disease	9.9%
138	Shwartzman Phenomenon	9.9%
139	Acanthoma	9.9%
140	Scurvy	9.8%
141	Purpura Fulminans	9.8%
142	Anemia, Pernicious	9.8%
143	Histiocytic Disorders, Malignant	9.5%
144	Kernicterus	8.9%
145	Lymphangiectasis, Intestinal	8.9%
146	Hamartoma	8.8%
147	Neoplasms, Hormone-Dependent	8.8%
148	Neoplasms, Multiple Primary	8.8%
149	Paraneoplastic Syndromes	8.8%
150	Precancerous Conditions	8.8%
151	Neoplasms, Second Primary	8.8%
152	Esophageal Neoplasms	8.7%
153	Thyroid Nodule	8.5%
154	POEMS Syndrome	8.5%
155	Lymphoproliferative Disorders	8.2%
156	Lymphatic Abnormalities	8.2%
157	Carcinoma, Lobular	8.2%
158	Mouth Neoplasms	8.1%
159	Central Nervous System Neoplasms	8.1%
160	Vascular Neoplasms	8.1%
161	Genital Neoplasms, Female	8%
162	Breast Neoplasms, Male	7.9%
163	Triple Negative Breast Neoplasms	7.9%
164	Lymphoma	7.9%
165	Testicular Neoplasms	7.8%
166	Carcinoma, Pancreatic Ductal	7.5%
167	Meningioma	7.3%
168	Cyst	7%
169	Neoplastic Processes	7%
170	Neoplastic Syndromes, Hereditary	7%
171	Pregnancy Complications, Neoplastic	7%
172	Multiple Endocrine Neoplasia Type 1	7%
173	Neoplasms, Experimental	6.9%
174	Adrenal Gland Neoplasms	6.8%
175	Gastrointestinal Neoplasms	6.8%
176	Genital Neoplasms, Male	6.8%
177	Liver neoplasms	6.8%
178	Uveal Neoplasms	6.8%
179	Mucocutaneous Lymph Node Syndrome	6.7%
180	Urologic Neoplasms	6.7%
181	Elephantiasis	6.7%
182	Hypersplenism	6.7%
183	Sarcoidosis	6.7%
184	Sebaceous Gland Neoplasms	6.7%
185	Spinal Neoplasms	6.7%
186	Elephantiasis Nostras Verrucosa	6.7%
187	Malignant histiocytosis	6.6%
188	Histiocytic sarcoma	6.6%
189	Composite Lymphoma	6.6%
190	Carcinoma 256, Walker	6.4%
191	Acoustic Neuroma	6.3%
192	insulinoma	6.3%
193	Vipoma	6.3%
194	Liver Neoplasms, Experimental	6.2%
195	Gastrinoma	6.2%
196	Glucagonoma	6.2%
197	Leukoplakia, Oral	6.2%
198	Paraneoplastic Cerebellar Degeneration	6.1%
199	Lymphomatoid Granulomatosis	6.1%
200	Nose Neoplasms	6.1%
201	Carcinoma, Ehrlich Tumor	6%
202	Dermoid Cyst	6%
203	Carcinoma, Lewis Lung	6%
204	Palatal Neoplasms	6%
205	Pseudoxanthoma Elasticum	6%
206	Meningeal Neoplasms	6%
207	Sezary Syndrome	5.9%
208	Neoplasms, Radiation-Induced	5.8%
209	Hepatocellular Adenoma	5.7%
210	Trophoblastic Neoplasms	5.6%
211	Retinoblastoma	5.6%
212	Lymphangioleiomyomatosis	5.6%
213	Leukemia, Experimental	5.6%
214	Melanoma, Experimental	5.5%
215	Pituitary Adenoma	5.5%
216	Pituitary Neoplasms	5.5%
217	Hodgkin Disease	5.5%
218	Lymphoma, Non-Hodgkin	5.5%
219	Neoplasms, Neuroepithelial	5.5%
220	Gliomatosis cerebri	5.5%
221	Granuloma	5.4%
222	Splenic Infarction	5.4%
223	Leydig Cell Tumor	5.4%
224	Limbic Encephalitis	5.3%
225	Histiocytosis, Langerhans-Cell	5.3%
226	Tumor Lysis Syndrome	5.3%
227	Neuroectodermal Tumors	5.3%
228	Optic Nerve Glioma	5.3%
229	Nephroblastoma	5.2%
230	Ear Neoplasms	5.1%
231	Erythroplasia	5.1%
232	Eyelid Neoplasms	5.1%
233	Follicular cyst	5.1%
234	leukemia	5.1%
235	Lung Neoplasms	5.1%
236	Mucocele	5.1%
237	Neoplasms, Germ Cell and Embryonal	5.1%
238	Neoplasms, Glandular and Epithelial	5.1%
239	Pilonidal Cyst	5.1%
240	Pleural Neoplasms	5.1%
241	Thyroglossal Cyst	5.1%
242	Synovial Cyst	5.1%
243	Germ Cell Cancer	5.1%
244	Aberrant Crypt Foci	5.1%
245	Tuberous Sclerosis	5.1%
246	Medulloblastoma	5%
247	Sarcoma, Experimental	5%
248	ovarian neoplasm	5%
249	Brain Neoplasms	5%
250	Salivary Gland Neoplasms	5%
251	Spinal Cord Neoplasms	5%
252	Tongue Neoplasms	5%
253	Lymphohistiocytosis, Hemophagocytic	5%
254	Erdheim-Chester Disease	5%
255	Prolactinoma	4.9%
256	Growth Hormone-Secreting Pituitary Adenoma	4.9%
257	Leukemia, T-Cell	4.9%
258	melanoma	4.9%
259	Uterine Neoplasms	4.9%
260	Vaginal Neoplasms	4.9%
261	Vulvar Neoplasms	4.9%
262	Uterine Cancer	4.9%
263	Meningeal Carcinomatosis	4.9%
264	Leukemia, B-Cell	4.9%
265	Fallopian Tube Neoplasms	4.9%
266	Lambert-Eaton Myasthenic Syndrome	4.8%
267	Leukemia, Radiation-Induced	4.8%
268	Carcinosarcoma	4.6%
269	Hemangiosarcoma	4.6%
270	Leukemia L1210	4.6%
271	Leukemia P388	4.6%
272	lymphangiosarcoma	4.6%
273	Splenic Rupture	4.5%
274	Choriocarcinoma	4.4%
275	Pharyngeal Neoplasms	4.4%
276	Adenoma, Acidophil	4.3%
277	Ganglioneuroma	4.3%
278	Glioma	4.3%
279	Lymphoma, Follicular	4.3%
280	T-Cell Lymphoma	4.3%
281	Malignant Glioma	4.3%
282	Mantle cell lymphoma	4.3%
283	granulosa cell tumor	4.3%
284	Carcinoma, Ovarian Epithelial	4.3%
285	Opsoclonus-Myoclonus Syndrome	4.3%
286	Central Nervous System Cysts	4.3%
287	Sarcoma 180	4.3%
288	Bile Duct Neoplasms	4.3%
289	gallbladder neoplasm	4.3%
290	Intestinal Neoplasms	4.3%
291	Penile Neoplasms	4.3%
292	Prostatic Neoplasms	4.3%
293	Stomach Neoplasms	4.3%
294	Bronchial Neoplasms	4.2%
295	Mesoblastic Nephroma	4.2%
296	Adenomatous Polyposis Coli	4.1%
297	Multiple Pulmonary Nodules	4.1%
298	Leukoplakia	4.1%
299	Pancreatic Cyst	4.1%
300	Supratentorial Neoplasms	4.1%
301	Carcinoid Tumor	4.1%
302	Endometrial Neoplasms	4.1%
303	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	4.1%
304	Neurilemmoma	4.1%
305	Hutchinson's Melanotic Freckle	4.1%
306	Adrenocortical carcinoma	4.1%
307	Melanoma, Amelanotic	4.1%
308	Leukemia, Large Granular Lymphocytic	4.1%
309	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	4.1%
310	Barrett Esophagus	4.1%
311	Breast Cyst	4.1%
312	Actinic keratosis	4.1%
313	Mediastinal Cyst	4.1%
314	Neoplasm Invasiveness	4.1%
315	Neoplasm Metastasis	4.1%
316	Neoplasm Recurrence, Local	4.1%
317	Parovarian Cyst	4.1%
318	Pericardial Cyst	4.1%
319	Thymic Cyst	4.1%
320	Carcinogenesis	4.1%
321	Myxoid cyst	4.1%
322	Metastasis	4.1%
323	Sarcoidosis, Pulmonary	4%
324	Basal cell carcinoma	3.9%
325	Carcinoma, Papillary	3.9%
326	Squamous cell carcinoma	3.9%
327	Chondrosarcoma	3.9%
328	Craniopharyngioma	3.9%
329	Cystadenoma	3.9%
330	leiomyosarcoma	3.9%
331	liposarcoma	3.9%
332	Mesothelioma	3.9%
333	synovial sarcoma	3.9%
334	Neuroectodermal Tumor, Melanotic	3.9%
335	Angiomyolipoma	3.9%
336	Clear Cell Sarcoma of Soft Tissue	3.9%
337	Alveolar Soft Part Sarcoma	3.9%
338	Neuroendocrine Tumors	3.9%
339	Sarcoma, Myeloid	3.9%
340	Carcinoma, Basal Cell	3.9%
341	Myelitis, Transverse	3.9%
342	Autoimmune Lymphoproliferative Syndrome	3.9%
343	Laryngeal neoplasm	3.9%
344	Leukemia, Plasma Cell	3.8%
345	Astrocytoma	3.8%
346	Ependymoma	3.8%
347	oligodendroglioma	3.8%
348	Lymphoma, T-Cell, Cutaneous	3.8%
349	Lymphoma, AIDS-Related	3.8%
350	Ganglioglioma	3.8%
351	gliosarcoma	3.8%
352	Anaplastic astrocytoma	3.8%
353	Anaplastic Oligodendroglioma	3.8%
354	Enteropathy-Associated T-Cell Lymphoma	3.8%
355	Primary Effusion Lymphoma	3.8%
356	Basal Cell Nevus Syndrome	3.7%
357	Bladder Neoplasm	3.7%
358	Kidney Neoplasm	3.7%
359	Ureteral Neoplasms	3.7%
360	Urethral Neoplasms	3.7%
361	Brain Stem Neoplasms	3.7%
362	Malignant Carcinoid Syndrome	3.6%
363	Cystadenocarcinoma	3.6%
364	Fibrosarcoma	3.6%
365	Osteosarcoma	3.6%
366	Mucoepidermoid Carcinoma	3.6%
367	Renal Cell Carcinoma	3.6%
368	Papillary Renal Cell Carcinoma	3.6%
369	Hypopharyngeal Neoplasms	3.5%
370	Pleural Effusion, Malignant	3.5%
371	Hypopharyngeal Cancer	3.5%
372	Glioblastoma	3.5%
373	Mycosis Fungoides	3.5%
374	Neuroblastoma	3.5%
375	Lymphomatoid Papulosis	3.5%
376	Glioblastoma Multiforme	3.5%
377	Plasmablastic lymphoma	3.5%
378	Parotid Neoplasms	3.5%
379	Prostatic Neoplasms, Castration-Resistant	3.5%
380	Nelson Syndrome	3.5%
381	Choroid Plexus Papilloma	3.4%
382	Adenofibroma	3.4%
383	Fibroadenoma	3.4%
384	Malignant Fibrous Histiocytoma	3.4%
385	Ganglioneuroblastoma	3.4%
386	Corpus Luteum Cyst	3.3%
387	Ovarian Cysts	3.3%
388	Adenoma	3.3%
389	Ameloblastoma	3.3%
390	Angiokeratoma	3.3%
391	Carcinoma	3.3%
392	Chordoma	3.3%
393	Hemangioma	3.3%
394	hemangiopericytoma	3.3%
395	Lymphangioma	3.3%
396	Mesenchymoma	3.3%
397	Nevus	3.3%
398	Teratoma	3.3%
399	Hepatoblastoma	3.3%
400	Mixed Tumor, Mullerian	3.3%
401	Germinoma	3.3%
402	Teratocarcinoma	3.3%
403	Angiofibroma	3.3%
404	Sarcoma	3.3%
405	Epithelioma	3.3%
406	Splenosis	3.3%
407	Carcinoma, Endometrioid	3.3%
408	Bowen's Disease	3.3%
409	Paraganglioma	3.3%
410	Rhabdomyosarcoma	3.3%
411	Giant Cell Tumor of Bone	3.3%
412	Nasopharyngeal carcinoma	3.2%
413	Tonsillar Neoplasms	3.1%
414	Cerebellar Neoplasms	3.1%
415	Dermatofibrosarcoma	3.1%
416	Dermatofibrosarcoma Protuberans	3.1%
417	Cecal Neoplasms	3.1%
418	Duodenal Neoplasms	3.1%
419	Endometrial Stromal Sarcoma	3%
420	Hydatidiform Mole	3%
421	Carcinoid Heart Disease	3%
422	Denys-Drash Syndrome	3%
423	Pheochromocytoma	2.9%
424	Alveolar rhabdomyosarcoma	2.9%
425	Neurofibrosarcoma	2.9%
426	Choledochal Cyst	2.9%
427	Peutz-Jeghers Syndrome	2.8%
428	Burkitt Lymphoma	2.8%
429	Nasopharyngeal Neoplasms	2.8%
430	Appendiceal Neoplasms	2.7%
431	Colonic Neoplasms	2.7%
432	Rectal Neoplasms	2.7%
433	Colorectal Neoplasms	2.7%
434	Pancreatic Pseudocyst	2.7%
435	Plasmacytoma	2.7%
436	Lymphatic Metastasis	2.6%
437	Neoplasms, Unknown Primary	2.6%
438	Leukemic Infiltration	2.6%
439	Neoplasm Micrometastasis	2.6%
440	Paranasal Sinus Neoplasms	2.5%
441	Adenocarcinoma	2.5%
442	Carcinoma in Situ	2.5%
443	Carcinoma, Transitional Cell	2.5%
444	Phyllodes Tumor	2.5%
445	Dysgerminoma	2.5%
446	Hemangioendothelioma	2.5%
447	Lipoma	2.5%
448	Myoma	2.5%
449	Myxoma	2.5%
450	Neuroma	2.5%
451	Papilloma	2.5%
452	Pseudomyxoma Peritonei	2.5%
453	Seminoma	2.5%
454	Papillomatosis	2.5%
455	Angiolipoma	2.5%
456	Myelolipoma	2.5%
457	Neoplasms, Bone Tissue	2.5%
458	Neoplasms, Fibrous Tissue	2.5%
459	Smooth Muscle Tumor	2.5%
460	Adenomatosis, Pulmonary	2.5%
461	Adenomatous Polyps	2.5%
462	Carcinoma, Large Cell	2.5%
463	Carcinoma, Small Cell	2.5%
464	Desmoplastic Small Round Cell Tumor	2.5%
465	Chondroma	2.5%
466	Enchondroma	2.5%
467	Anus Neoplasms	2.3%
468	Sigmoid Neoplasms	2.3%
469	Maxillary Sinus Neoplasms	2.2%
470	Polycystic Ovary Syndrome	2.2%
471	Adenoid Cystic Carcinoma	2.1%
472	fibroma	2.1%
473	Fibromatosis	2.1%
474	Osteoblastoma	2.1%
475	Osteoma	2.1%
476	Rhabdomyoma	2.1%
477	Chondromatosis	2.1%
478	Adenocarcinoma, Clear Cell	2.1%
479	Cholangiocarcinoma	2.1%
480	Cervical Intraepithelial Neoplasia	2.1%
481	Hemangioblastoma	2.1%
482	Lymphoma, Extranodal NK-T-Cell	2.1%
483	Primary amyloidosis	1.9%
484	Fibromatosis, Aggressive	1.8%
485	Fibromatosis, Abdominal	1.8%
486	Klatskin Tumor	1.8%
487	Xeroderma Pigmentosum	1.8%
488	Mastocytosis	1.7%
489	Sturge-Weber Syndrome	1.7%
490	Cell Transformation, Viral	1.7%
491	Gastrointestinal Stromal Tumors	1.7%
492	Mastocytoma	1.7%
493	Mastocytosis, Systemic	1.6%
494	neurofibroma	1.6%
495	Zollinger-Ellison syndrome	1.3%
496	Dupuytren Contracture	1.3%
497	Urticaria Pigmentosa	1.2%
498	Niemann-Pick Disease, Type C	1.2%
499	Radicular Cyst	0.9%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234